Compare BCRX & DCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BCRX | DCO |
|---|---|---|
| Founded | 1986 | 1849 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Military/Government/Technical |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.9B |
| IPO Year | 1995 | 1995 |
| Metric | BCRX | DCO |
|---|---|---|
| Price | $9.81 | $139.19 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 11 | 5 |
| Target Price | $20.82 | ★ $149.80 |
| AVG Volume (30 Days) | ★ 5.9M | 152.3K |
| Earning Date | 05-04-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 381.40 | N/A |
| EPS | ★ 1.21 | N/A |
| Revenue | $25,186,000.00 | ★ $824,730,000.00 |
| Revenue This Year | N/A | $7.40 |
| Revenue Next Year | $12.55 | $8.59 |
| P/E Ratio | $8.07 | ★ N/A |
| Revenue Growth | N/A | ★ 4.85 |
| 52 Week Low | $6.00 | $53.71 |
| 52 Week High | $11.31 | $143.33 |
| Indicator | BCRX | DCO |
|---|---|---|
| Relative Strength Index (RSI) | 64.16 | 67.40 |
| Support Level | $7.85 | $87.68 |
| Resistance Level | $10.32 | $140.02 |
| Average True Range (ATR) | 0.56 | 4.75 |
| MACD | -0.05 | 1.34 |
| Stochastic Oscillator | 63.99 | 85.11 |
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
Ducommun Inc provides engineering & manufacturing services for high-performance products & high-cost-of failure applications used in the aerospace and defense, industrial, medical & other industries. The company's reportable segments are Structural Systems & Electronic Systems. Structural Systems designs, engineers and manufactures various sizes of complex contoured aerostructure components and assemblies and supplies composite and metal bonded structures and assemblies. Electronic Systems designs, engineers and manufactures high-reliability electronic and electromechanical products used in technology-driven markets including A&D and Industrial end-use markets. It generates maximum of its revenue from the Electronic Systems.